FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/10/096684 [Registered on: 30/10/2025] Trial Registered Prospectively
Last Modified On: 18/08/2026
Post Graduate Thesis  No 
Type of Trial  PMS 
Type of Study   Medical Device 
Study Design  Single Arm Study 
Public Title of Study   A study on patients undergoing knee ligament or tendon repair using arthroscopic implants to assess safety and recovery outcomes. 
Scientific Title of Study   Arthroscopy Implants for Knee:A Prospective, Observational, Multi-centre, Single-arm, Open-label, Post-market Clinical Followup Study to Evaluate Safety and Performance of the Arthroscopy Implants for Knee in a RealWorld Setting. 
Trial Acronym  NIL 
Secondary IDs if Any
Modification(s)  
Secondary ID  Identifier 
MHCPL/Arthroscopy Implants for Knee V2.0.0 01-Jul-2026  Protocol Number 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Kirankumar Shetty 
Designation  AGM-Product Performance & Engineering Department 
Affiliation  Meril Life Sciences Pvt. Ltd 
Address  Meril Life Sciences Pvt. Ltd, Buiding number 6, 3rd floor, Near BilakhiaStadium,Surveyno 135,139,Muktanand marg, Chala, Vapi-396191

Valsad
GUJARAT
396191
India 
Phone  9743700109  
Fax    
Email  kirankumar.shetty@merillife.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kirankumar Shetty 
Designation  AGM-Product Performance & Engineering Department 
Affiliation  Meril Life Sciences Pvt. Ltd 
Address  Meril Life Sciences Pvt. Ltd, Buiding number 6, 3rd floor, Near BilakhiaStadium,Surveyno 135,139,Muktanand marg, Chala, Vapi-396191


GUJARAT
396191
India 
Phone  9743700109  
Fax    
Email  kirankumar.shetty@merillife.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kirankumar Shetty 
Designation  AGM-Product Performance & Engineering Department 
Affiliation  Meril Life Sciences Pvt. Ltd 
Address  Meril Life Sciences Pvt. Ltd, Buiding number 6, 3rd floor, Near BilakhiaStadium,Surveyno 135,139,Muktanand marg, Chala, Vapi-396191


GUJARAT
396191
India 
Phone  9743700109  
Fax    
Email  kirankumar.shetty@merillife.com  
 
Source of Monetary or Material Support  
Meril Healthcare Pvt. Ltd. Meril Park, H1-H3, Survey No. 1575 and 1088, Muktanand Marg, Chala, Vapi, Valsad, Gujarat– 396191 
 
Primary Sponsor  
Name  Meril Life Sciences Pvt Ltd 
Address  Near Bilakhia Stadium, Survey no 135/139,Muktanand marg, Chala, Vapi-396191,Gujarat, India 
Type of Sponsor  Other [Medical Device Company ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study
Modification(s)  
No of Sites = 6  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Vinay Tantuway   Arthros Multispecialty Hospital,  Ground Floor, Department of Orthopedics, 328/2/4/1 Dargah Bypass, Link Road, MR-9, Khajrana, Indore, Madhya Pradesh 452016
Indore
MADHYA PRADESH 
9893430089

vinayforever@gmail.com 
Dr Achal Saradava  HCG Hospital  Department of Orthopedics , Near Aastha Avenue, 150 Feet Ring Road, Ayodhya Chowk, Rajkot, Gujarat 360006
Rajkot
GUJARAT 
9426449977

dr.achal.saradava@gmail.com 
Dr Umesh Jadhav  PanOrtho Hospital  Department of Orthopedics, Plot no.F11, Sector number 26,Chhatrapati Sambhaji Maharaj Chowk,Pradhikaran, Nigdi, Pimpri-Chinchwad, Maharastra 411044
Pune
MAHARASHTRA 
9822478288

umeshortho@gmail.com 
Dr Chintan Vadi  Restore Orthocare Hospital  Department of Arthroscopy & Sports Medicine Specialist, 5/6/7 Floor, Amruta Enclave, Mavdi Police Head Quarter Road, Near Suvarnabhoomi Heights, Speedwell Chowk, Rajkot, Gujarat, 360005, India
Rajkot
GUJARAT 
9879678767

chintanvadi@gmail.com 
Dr Bhamare D S  Sainath Hospital  Sant Nagar, Pune - Nashik Hwy, Moshi Pradhikaran, Moshi, Pimpri-Chinchwad, Maharashtra 411070
Pune
MAHARASHTRA 
7507899338

drbhamareds@gmail.com 
Dr Tejas Waghela  Shree Narayan Hospital  Department of Arthroscopy and Ortho opp. RLT College, New Radhakisan Plots, Civil LinesAkola, Akola, Maharashtra
Akola
MAHARASHTRA 
7666245498

drtejaswaghela@gmail.com 
 
Details of Ethics Committee
Modification(s)  
No of Ethics Committees= 6  
Name of Committee  Approval Status 
Central Independent Ethics Committee  Approved 
Central Independent Ethics Committee  Approved 
EC N M VIRANI WOCKHARDTHOSPITAL  Approved 
ETHICS COMMITTEE N M VIRANI WOCKHARDT HOSPITAL  Approved 
Lotus Superspeciality Hospital  Approved 
Rectitude ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M179||Osteoarthritis of knee, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  1. Arthroscopy Knee System implants are intended to be used in both men and non-pregnant women of age 18 years or above.
2. The Participants who are eligible for the arthroscopy system which is used in the surgical procedures related to knee ligament fracture fixation are included in the study.
3. The Participants who require connective tissue tendon repairs for the knees.
4. Participants who require the attachment of soft tissue grafts or bone-tendon grafts to the tibia and/or femur during cruciate ligament reconstruction surgeries and fixation of soft tissue.
5. The patient is willing and able to comply with postoperative scheduled clinical evaluations. 
 
ExclusionCriteria 
Details  1.Systemic or acute or chronic infection at the surgical site.
2. Known allergy or sensitivity to product materials.
3. Insufficient tissue coverage in the surgical area.
4. Any medical or surgical condition that would preclude the potential benefit of the operation.
5. Fever or leukocytosis.
6. Long-term infection, pregnancy and nursing, radiation bone therapy, cardiovascular diseases, metabolic bone disease, renal diseases, and pediatric Participants should not be included in the study.
7. Participants within whom cooperation or mental
competence is lacking, thereby reducing Participants compliance.
8. The Participants, being considered for treatment by a doctor, would not comply with the follow-up schedule.
9. Participants who is unwilling or unsuitable for
postoperative instructions.
10. The Participants who is unwilling or unable to sign the Informed Consent Document will be excluded from the study 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1.Implant failure rate
2.Reoperation rate
3.Physical Function 
1.Time Frame: Intra-operative, 3 weeks, 3 months, 6 months, 1 year, 2 years
2.Time Frame: 3 weeks, 3 months, 6 months, 1 year, 2 years
3.Time Frame: Pre-operative, 3 weeks, 3 months, 6 months, 1 year, 2 years 
 
Secondary Outcome
Modification(s)  
Outcome  TimePoints 
1.Implant failure rate
2.Reoperation rate
3.Physical Function
4.Pain Score
5.Wound Complications
6. Intra-operative Complications
7.Length of Hospital Stay
8. SF-12 Questionnaire
9. Radiographic Analysis 
Timeframe- Pre Operative, Intra Operative, Discharge, Post Operative, 3 week, 3 months, 6 months, 1 year, 2 years, 3 years, 4 years, 5 years 
 
Target Sample Size   Total Sample Size="107"
Sample Size from India="107" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Post Marketing Surveillance 
Date of First Enrollment (India)   29/11/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="5"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Study Name: A Prospective, Observational, Multi-centre, Single-arm, Openlabel, Post-market Clinical Follow-up Study to Evaluate Safety and Performance of the Arthroscopy Implants for Knee in a RealWorld Setting. 

Short Title: Arthroscopy Implants for Knee

Objective: The study aims to evaluate the safety and performance of arthroscopy implants in participants undergoing knee surgeries. 

Study Design: A Prospective, Observational, Multi-centre, Single-arm, Openlabel, Post-market Clinical Follow-up Study.


Rationale of the Study Arthroscopy implants have become essential tools in minimally invasive orthopedic procedures, particularly for treating conditions in the shoulder, elbow, and hand/wrist joints. These procedures allow for targeted interventions, offering participants faster recovery times, less post- operative pain, and improved mobility compared to traditional open surgeries. However, there remains a need to comprehensively assess the safety and performance of these implants in real- world settings, where participant populations may vary significantly from clinical trials. This study is designed to evaluate the safety and performance of arthroscopy implants in Participants undergoing knee surgeries 
Close